 WAKEFIELD, Mass., Jan. 29, 2021 GLOBE NEWSWIRE -- Innovation Pharmaceuticals OTCQB:IPIX the Company, a clinical stage biopharmaceutical company, announces today that the Companys Phase 2 clinical trial of Brilacidin for treating COVID-19 is scheduled to begin next week. 